428 related articles for article (PubMed ID: 21246561)
21. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
[TBL] [Abstract][Full Text] [Related]
22. A novel method for the separation of mono and ortho polymorphs of paracetamol in gel matrix.
Sudha C; Parimaladevi P; Srinivasan K
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():150-5. PubMed ID: 25492183
[TBL] [Abstract][Full Text] [Related]
23. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
Niederwanger V; Gozzo F; Griesser UJ
J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
[TBL] [Abstract][Full Text] [Related]
24. Structural characterization of two polymorphic forms of piroxicam pivalate.
Caira MR; Zanol M; Peveri T; Gazzaniga A; Giordano F
J Pharm Sci; 1998 Dec; 87(12):1608-14. PubMed ID: 10189275
[TBL] [Abstract][Full Text] [Related]
25. Characterization and selective crystallization of famotidine polymorphs.
Lu J; Wang XJ; Yang X; Ching CB
J Pharm Sci; 2007 Sep; 96(9):2457-68. PubMed ID: 17518361
[TBL] [Abstract][Full Text] [Related]
26. A conformational polymorphic transition in the high-temperature epsilon-form of chlorpropamide on cooling: a new epsilon'-form.
Drebushchak TN; Chesalov YA; Boldyreva EV
Acta Crystallogr B; 2009 Dec; 65(Pt 6):770-81. PubMed ID: 19923705
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD
J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935
[TBL] [Abstract][Full Text] [Related]
28. New solvates of an old drug compound (phenobarbital): structure and stability.
Zencirci N; Griesser UJ; Gelbrich T; Kahlenberg V; Jetti RK; Apperley DC; Harris RK
J Phys Chem B; 2014 Mar; 118(12):3267-80. PubMed ID: 24571055
[TBL] [Abstract][Full Text] [Related]
29. Polymorphs of tamoxifen citrate: detailed structural characterization of the stable form.
Goldberg I; Becker Y
J Pharm Sci; 1987 Mar; 76(3):259-64. PubMed ID: 3585745
[TBL] [Abstract][Full Text] [Related]
30. Indomethacin polymorphs: Experimental and conformational analysis.
Aceves-Hernandez JM; Nicolás-Vázquez I; Aceves FJ; Hinojosa-Torres J; Paz M; Castaño VM
J Pharm Sci; 2009 Jul; 98(7):2448-63. PubMed ID: 19199282
[TBL] [Abstract][Full Text] [Related]
31. Crystal polymorphs of barbital: news about a classic polymorphic system.
Zencirci N; Griesser UJ; Gelbrich T; Apperley DC; Harris RK
Mol Pharm; 2014 Jan; 11(1):338-50. PubMed ID: 24283960
[TBL] [Abstract][Full Text] [Related]
32. Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.
Araya-Sibaja AM; Soldi V; Campos CE; Cardoso SG; Cuffini SL
Drug Dev Ind Pharm; 2015 May; 41(5):851-8. PubMed ID: 24758712
[TBL] [Abstract][Full Text] [Related]
33. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
Li Y; Chow PS; Tan RB
Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
[TBL] [Abstract][Full Text] [Related]
34. Eu(III) and Tb(III) complexes with the nonsteroidal anti-inflammatory drug carprofen: synthesis, crystal structure, and photophysical properties.
Zhou X; Zhao X; Wang Y; Wu B; Shen J; Li L; Li Q
Inorg Chem; 2014 Dec; 53(23):12275-82. PubMed ID: 25402730
[TBL] [Abstract][Full Text] [Related]
35. Mefenamic acid anti-inflammatory drug: probing its polymorphs by vibrational (IR and Raman) and solid-state NMR spectroscopies.
Cunha VR; Izumi CM; Petersen PA; Magalhães A; Temperini ML; Petrilli HM; Constantino VR
J Phys Chem B; 2014 Apr; 118(16):4333-44. PubMed ID: 24654805
[TBL] [Abstract][Full Text] [Related]
36. Structural characteristics and crystal polymorphism of three local anaesthetic bases crystal polymorphism of local anaesthetic drugs: part VII.
Schmidt AC
Int J Pharm; 2005 Jul; 298(1):186-97. PubMed ID: 15955643
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of a novel sodium ion channel blocker.
Cheung EY; Harris KD; Johnston RL; Hadden KL; Zakrzewski M
J Pharm Sci; 2003 Oct; 92(10):2017-26. PubMed ID: 14502541
[TBL] [Abstract][Full Text] [Related]
38. (14) N nuclear quadrupole resonance study of piroxicam: confirmation of new polymorphic form V.
Lavrič Z; Pirnat J; Lužnik J; Puc U; Trontelj Z; Srčič S
J Pharm Sci; 2015 Jun; 104(6):1909-1918. PubMed ID: 25776345
[TBL] [Abstract][Full Text] [Related]
39. Crystal forms of naproxen.
Song JS; Sohn YT
Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
[TBL] [Abstract][Full Text] [Related]
40. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
Tong HH; Shekunov BY; York P; Chow AH
Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
